| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.793 | 1.191 | 709 | 465 | 225 | 146 | 28 | 0 | 0 | 0 |
| Total Income - EUR | 4.889 | 4.256 | 1.511 | 1.090 | 838 | 747 | 28 | 0 | 0 | 0 |
| Total Expenses - EUR | 4.835 | 3.802 | 1.370 | 1.196 | 1.024 | 719 | 162 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 54 | 454 | 141 | -106 | -186 | 29 | -134 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | 418 | 120 | -120 | -193 | 24 | -135 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Miere Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.726 | 12.501 | 11.488 | 10.652 | 9.833 | 9.046 | 8.845 | 8.872 | 8.845 | 8.796 |
| Current Assets | 1.191 | 694 | 1.044 | 1.114 | 906 | 917 | 763 | 765 | 763 | 759 |
| Inventories | 776 | 355 | 903 | 918 | 720 | 601 | 587 | 589 | 587 | 584 |
| Receivables | 112 | 167 | 55 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 303 | 173 | 86 | 195 | 185 | 316 | 175 | 176 | 175 | 174 |
| Shareholders Funds | -4.436 | -3.973 | -3.786 | -3.836 | -3.955 | -3.856 | -3.905 | -3.917 | -3.905 | -3.883 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.292 | 17.168 | 7.422 | 7.495 | 7.357 | 7.222 | 7.062 | 7.084 | 7.063 | 7.023 |
| Income in Advance | 13.061 | 9.863 | 8.895 | 8.107 | 7.337 | 6.597 | 6.450 | 6.470 | 6.451 | 6.415 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Miere Bio S.r.l.